Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Targeted Therapy Treatment Innovations in AML : Episode 1
Role of First Generation FLT3 Inhibitors in AML
Expert discusses the role of FLT3 inhibitors in the treatment of AML and if benefit from midostaurin in combination with chemotherapy can be predicted.
Now Viewing
EP: 1.Role of First Generation FLT3 Inhibitors in AML
EP: 2.Role of Second Generation FLT3 Inhibitors in AML
EP: 3.Part 1: IDH1 & IDH2 Inhibitors In Newly Diagnosed AML
EP: 4.Part 2: IDH1 & IDH2 Inhibitors In Newly Diagnosed AML
EP: 5.Role of Venetoclax in Treatment of AML
EP: 6.Part 1: Practical Considerations For Venetoclax in AML
EP: 7.Part 2: Practical Considerations For Venetoclax in AML
EP: 8.5-Year Follow-Up Data For CPX-351 in AML
EP: 9.CPX-351 in Clinical Practice For AML
Recent Videos
Related Content
